Relationship of circulating anti-C3b and anti-C1q IgG to lupus nephritis and its flare

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 1, 2016, Pages 47-53

  Birmingham, Daniel J ^a   Bitter, Joshua E ^a   Ndukwe, Ezinne G ^a   Dials, Sarah ^a   Gullo, Terese R ^a   Conroy, Sara ^b   Nagaraja, Haikady N ^b   Rovin, Brad H ^a   Hebert, Lee A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3B ANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEINURIA; BLOOD; CROSS-SECTIONAL STUDY; IMMUNOLOGY; LONGITUDINAL STUDY;

ADULT; AUTOANTIBODIES; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT C3B; COMPLEMENT C4; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; LUPUS NEPHRITIS; MALE;

EID: 84954435105     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03990415     Document Type: Article

References (22)

1. Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F: IgG autoantibodies against C1q are correlated with nephritis, hypo-complementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 18: 230-234, 1991
2. Yin Y, Wu X, Shan G, Zhang X: Diagnostic value of serum anti- C1q antibodies in patients with lupus nephritis: A meta-analysis.Lupus 21: 1088-1097, 2012
3. Rovin BH, Tang Y, Sun J, Nagaraja HN, Hackshaw KV, Gray L, Rice R, Birmingham DJ, Yu CY, Spetie DN, Aziz A, Hebert LA: Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int 68: 747-759, 2005
4. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN: Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 16: 467-473, 2005
5. Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Li X, Hackshaw KV, Yu CY, Malarkey WB, Hebert LA: Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A-1019 G allele. Arthritis Rheum 54: 3291-3299, 2006
6. Birmingham DJ, Hebert LA, Song H, Noonan WT, Rovin BH, Nagaraja HN, Yu CY: Evidence that abnormally large seasonal Anti-C3b, Anti-C1q, and Lupus Nephritis, Birmingham et al. 53 declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 21: 855-864, 2012
7. Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjoholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR: Functional analysis of the classical, alternative, and MBL pathways of the complement system: Standardization and validation of a simple ELISA. J Immunol Methods 296: 187-198, 2005
8. Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G:Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci 1173: 47-51, 2009
9. Kohro-Kawata J, Wener MH, Mannik M: The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus eryth ematosus. J Rheumatol 29: 84-89, 2002
10. Antes U, Heinz HP, Loos M: Evidence for the presence of auto- antibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum 31: 457-464, 1988
11. Wisnieski JJ, Jones SM: Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Im- munol 148: 1396-1403, 1992
12. Vanhecke D, Roumenina LT, Wan H, Osthoff M, Schaller M, Trendelenburg M: Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immune sorbent assay. Arthritis Rheum 64: 3706-3714, 2012
13. Mannik M, Wener MH: Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 40: 1504-1511, 1997
14. Lachmann PJ: Conglutinin and immunoconglutinins. Adv Immunol 6: 479-527, 1967
15. Durand CG, Burge JJ: A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus. J Immunol Methods 73: 57-66, 1984
16. Nilsson B, Ekdahl KN, Svarvare M, Bjelle A, Nilsson UR: Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: Implications for a regulatory function. Clin Exp Immunol 82: 262-267, 1990
17. Nilsson B, Ekdahl KN, Sjoholm A, Nilsson UR, Sturfelt G: Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): Serial analysis in relation to disease course. Clin Exp Immunol 90: 251-255, 1992
18. Isenman DE, Cooper NR: The structure and function of the third component of human complement-I. The nature and extent of conformational changes accompanying C3 activation. Mol Im- munol 18: 331-339, 1981
19. Alsenz J, Becherer JD, Nilsson B, Lambris JD: Structural and functional analysis of C3 using monoclonal antibodies. Curr Top Microbiol Immunol 153: 235-248, 1990
20. Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH: The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 19: 1272-1280, 2010
21. Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA, Kishore U, Salant DJ, Verbeek JS, van Kooten C, Daha MR: Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114: 679-688, 2004
22. Kenyon KD, Cole C, Crawford F, Kappler JW, Thurman JM, Bratton DL, Boackle SA, Henson PM: IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity. J Immunol 187: 2101-2111, 2011